Effect of information management platformon the follow-up and anticoagulant therapy of 6 923 patients with atrial fibrillation
刘韦卓,周鹏,吴帮卫,熊楠青,谢坤,包丽雯,高秀芳,王玉涛,施海明,罗心平,李剑
DOI: https://doi.org/10.3760/cma.j.cn.113859-20190515-00124
2020-01-01
Abstract:Objective:The comprehensive management of atrial fibrillation (AF) plays a critical role in its prognosis. This research was to observe the intervention effect of a computer-aided comprehensive management platform for AF patients, which was established to help strengthen the early diagnosis, standardized treatment, and long-term follow-up of patients with AF in Huashan Hospital, Fudan University.Methods:We compared and analyzed the clinical characteristics of patients diagnosed as AF from January 2015 to February 2019 in Huashan Hospital Fudan University, who were classified into pre-platform (group A) and post-platform (group B) group including demography variates, comorbidities, CHA
2DS
2-VASc score, treatments and so on.
Results:①There were 3 538 patients (numbers of visits: 8 343) in group A and 3 385 patients (numbers of visits: 13 294) in group B with an average age of 74.31 and 73.86 years, respectively. ②A raise in the number of annual physician office visits were shown with increased proportion of outpatient visits (A: 75.4%, B: 86.1%) , decreased proportion of inpatients (A: 12.5%, B: 6.1%) and emergency visits (A: 12.1%, B: 7.8%) . ③The median CHA
2DS
2-VASc score of group A was 3, and 2 of group B. Top three comorbidities were hypertension (A: 32.8%, B: 21.7%,
P<0.001) , coronary heart disease (A: 13.4%, B: 8.2%,
P<0.001) , diabetes mellitus (A: 12.5%, B: 11.3%,
P<0.001) in both groups.④The use of anticoagulant was 22.6% (1 885/8 343) in group A and 67.0% (8 913/13 294) in group B and antiplatelet agents used in the two groups were 19.7% (1 645/8 343) and 5.6% (738/13 294) .
Conclusion:The medical compliance of patients with AF was significantly increased with the help of computer-assisted platform, especially demonstrated by the decrease on the loss of follow-up among the "low score" (CHA
2DS
2-VASc score≤2) population.The comprehensive management platform provides a multi-dimensional support for thelong-term follow-up and self-health management of AF patients.